Risperidone and associated amenorrhea

A report of 5 cases

Yong Ku Kim, Leen Kim, Min-Soo Lee

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Background: We report a 5-case series in which risperidone use in usual or lower-than-usual doses was unexpectedly associated with amenorrhea. Case Reports: On regimens of risperidone (1-8 mg/day), 5 psychiatric patients with various diagnoses developed amenorrhea with elevated serum prolactin levels (mean = 121.7 ng/mL; range, 612-229.8 ng/mL). In 4 of 5 cases, menstruation resumed only when risperidone was withdrawn, and in 1 case, menstruation restarted when the dose was tapered. Follow-up serum prolactin levels dropped to a mean of 17.2 ng/mL (range, 6.4-37.6 ng/mL). Conclusion: These findings indicate that the occurrence of amenorrhea during risperidone treatment may be related to elevated serum prolactin levels. This phenomenon may be due either to the dopamine D2 blocking effect of risperidone or to the large individual variability in the rate at which risperidone is metabolized.

Original languageEnglish
Pages (from-to)315-317
Number of pages3
JournalJournal of Clinical Psychiatry
Volume60
Issue number5
DOIs
Publication statusPublished - 1999 Jan 1

Fingerprint

Risperidone
Amenorrhea
Prolactin
Menstruation
Serum
Psychiatry
Dopamine

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Risperidone and associated amenorrhea : A report of 5 cases. / Kim, Yong Ku; Kim, Leen; Lee, Min-Soo.

In: Journal of Clinical Psychiatry, Vol. 60, No. 5, 01.01.1999, p. 315-317.

Research output: Contribution to journalArticle

@article{a7ceee83eb4343b5bc4aabea0a9614b0,
title = "Risperidone and associated amenorrhea: A report of 5 cases",
abstract = "Background: We report a 5-case series in which risperidone use in usual or lower-than-usual doses was unexpectedly associated with amenorrhea. Case Reports: On regimens of risperidone (1-8 mg/day), 5 psychiatric patients with various diagnoses developed amenorrhea with elevated serum prolactin levels (mean = 121.7 ng/mL; range, 612-229.8 ng/mL). In 4 of 5 cases, menstruation resumed only when risperidone was withdrawn, and in 1 case, menstruation restarted when the dose was tapered. Follow-up serum prolactin levels dropped to a mean of 17.2 ng/mL (range, 6.4-37.6 ng/mL). Conclusion: These findings indicate that the occurrence of amenorrhea during risperidone treatment may be related to elevated serum prolactin levels. This phenomenon may be due either to the dopamine D2 blocking effect of risperidone or to the large individual variability in the rate at which risperidone is metabolized.",
author = "Kim, {Yong Ku} and Leen Kim and Min-Soo Lee",
year = "1999",
month = "1",
day = "1",
doi = "10.4088/JCP.v60n0509",
language = "English",
volume = "60",
pages = "315--317",
journal = "Journal of Clinical Psychiatry",
issn = "0160-6689",
publisher = "Physicians Postgraduate Press Inc.",
number = "5",

}

TY - JOUR

T1 - Risperidone and associated amenorrhea

T2 - A report of 5 cases

AU - Kim, Yong Ku

AU - Kim, Leen

AU - Lee, Min-Soo

PY - 1999/1/1

Y1 - 1999/1/1

N2 - Background: We report a 5-case series in which risperidone use in usual or lower-than-usual doses was unexpectedly associated with amenorrhea. Case Reports: On regimens of risperidone (1-8 mg/day), 5 psychiatric patients with various diagnoses developed amenorrhea with elevated serum prolactin levels (mean = 121.7 ng/mL; range, 612-229.8 ng/mL). In 4 of 5 cases, menstruation resumed only when risperidone was withdrawn, and in 1 case, menstruation restarted when the dose was tapered. Follow-up serum prolactin levels dropped to a mean of 17.2 ng/mL (range, 6.4-37.6 ng/mL). Conclusion: These findings indicate that the occurrence of amenorrhea during risperidone treatment may be related to elevated serum prolactin levels. This phenomenon may be due either to the dopamine D2 blocking effect of risperidone or to the large individual variability in the rate at which risperidone is metabolized.

AB - Background: We report a 5-case series in which risperidone use in usual or lower-than-usual doses was unexpectedly associated with amenorrhea. Case Reports: On regimens of risperidone (1-8 mg/day), 5 psychiatric patients with various diagnoses developed amenorrhea with elevated serum prolactin levels (mean = 121.7 ng/mL; range, 612-229.8 ng/mL). In 4 of 5 cases, menstruation resumed only when risperidone was withdrawn, and in 1 case, menstruation restarted when the dose was tapered. Follow-up serum prolactin levels dropped to a mean of 17.2 ng/mL (range, 6.4-37.6 ng/mL). Conclusion: These findings indicate that the occurrence of amenorrhea during risperidone treatment may be related to elevated serum prolactin levels. This phenomenon may be due either to the dopamine D2 blocking effect of risperidone or to the large individual variability in the rate at which risperidone is metabolized.

UR - http://www.scopus.com/inward/record.url?scp=0032993709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032993709&partnerID=8YFLogxK

U2 - 10.4088/JCP.v60n0509

DO - 10.4088/JCP.v60n0509

M3 - Article

VL - 60

SP - 315

EP - 317

JO - Journal of Clinical Psychiatry

JF - Journal of Clinical Psychiatry

SN - 0160-6689

IS - 5

ER -